CAS 119141-88-7

(-)-Omeprazol

Descripción:

(-)-Omeprazol es un inhibidor de la bomba de protones (IBP) utilizado principalmente para tratar condiciones como la enfermedad por reflujo gastroesofágico (ERGE) y las úlceras pépticas al reducir la producción de ácido estomacal. Se caracteriza por su naturaleza quiral, existiendo como un solo enantiómero, lo que contribuye a su actividad farmacológica. El compuesto tiene una fórmula molecular que incluye elementos como carbono, hidrógeno, nitrógeno y oxígeno, reflejando su estructura compleja que presenta un anillo de benzimidazol y un grupo piridina. (-)-Omeprazol se administra típicamente en su forma recubierta entérica para asegurar la estabilidad y absorción en el tracto gastrointestinal. Su mecanismo de acción implica la inhibición irreversible de la enzima H+/K+ ATPasa en las células parietales gástricas, lo que lleva a una disminución de la secreción ácida. La sustancia es generalmente bien tolerada, aunque puede tener efectos secundarios, incluyendo trastornos gastrointestinales y posibles interacciones con otros medicamentos. Debido a su acción específica y eficacia, (-)-Omeprazol sigue siendo un medicamento ampliamente prescrito en el manejo de trastornos relacionados con el ácido.

Fórmula: C₁₇H₁₉N₃O₃S

InChI: InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)/t24-/m0/s1

Clave InChI: InChIKey=SUBDBMMJDZJVOS-DEOSSOPVSA-N

SMILES: S(CC1=C(C)C(OC)=C(C)C=N1)(=O)C=2NC=3C(N2)=CC=C(OC)C3

Sinónimos:

• (-)-Omeprazole
• (5-methoxy-1H-benzimidazol-2-yl)[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfoniumolate
• (S)-(-)-Omeprazole
• (S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
• (S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole
• (S)-6-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole
• (S)-Esomeprazole
• 1H-Benzimidazole, 5-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-
• 1H-Benzimidazole, 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-, (S)-
• 1H-Benzimidazole, 6-methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-
• 5-Methoxy-2-((S)-((4-methoxy-3,5-dimethyl-2- pyridinyl)methyl)sulfinyl)-1H-benzimidazole
• 6-Methoxy-2-[(R)-(4-methoxy-3,5-dimethyl-pyridin-2-yl)methylsulfinyl]-1H-benzoimidazole
• 6-Methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
• 6-methoxy-2-{(R)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
• 6-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
• 6-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole
• Esofag
• Esomeprazole(Mg)
• Esomeprazole(Na、Mg)
• Inexium

Esomeprazole

CAS: 119141-88-7

Fórmula: C₁₇H₁₉N₃O₃S

Pureza: 99%

Forma y color: Solid

Peso molecular: 345.4161

Ref: IN-DA0077XZ

Esomeprazole-d3

CAS: 119141-88-7

Fórmula: C₁₇H₁₆D₃N₃O₃S

Forma y color: Pale Yellow Solid

Peso molecular: 348.44

Ref: 4Z-O-0216

Esomeprazole

CAS: 119141-88-7

Esomeprazole

Pureza: ≥98%

Peso molecular: 345.42g/mol

Ref: 54-BUP17319

Esomeprazole

CAS: 119141-88-7

Esomeprazole

Pureza: 99%

Peso molecular: 345.42g/mol

Ref: 54-OR1028226

(S)-6-Methoxy-2-(((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole

CAS: 119141-88-7

Pureza: 95.0%

Forma y color: Solid

Peso molecular: 345.4200134277344

Ref: 10-F219545

Esomeprazole

CAS: 119141-88-7

Esomeprazole is the S-isomer of omeprazole, inhibits the lysosomal cysteine protease legumain to prevent cancer metastasis.

Fórmula: C₁₇H₁₉N₃O₃S

Pureza: 97.3%

Forma y color: Solid

Peso molecular: 345.42

Ref: TM-T20626

Esomeprazole-d3 Sodium

Producto controlado

CAS: 119141-88-7

Fórmula: C₁₇H₁₅D₃N₃NaO₃S

Forma y color: Neat

Peso molecular: 370.42

Ref: TR-E668302

Esomeprazole

CAS: 119141-88-7

Esomeprazole is a drug used for treating gastroesophageal reflux disease (GERD). It belongs to the class of proton pump inhibitors (PPIs) and inhibits gastric acid secretion by binding to the H+/K+-ATPase enzyme in the stomach. It has been shown to inhibit various drug interactions, including those with inhibitor drugs, nonsteroidal anti-inflammatory drugs, control analysis, enzyme activities, blood sampling, and more. Esomeprazole also has inhibitory properties that may be due to its ability to reduce gastric acidity and its esomeprazole content. Esomeprazole is used as a treatment for GERD and other conditions such as Zollinger-Ellison syndrome. Omeprazole is another PPI that is sometimes used instead of esomeprazole.

Fórmula: C₁₇H₁₉N₃O₃S

Pureza: Min. 95%

Peso molecular: 345.42 g/mol

Ref: 3D-FE61562